Share

Pivotal Clinical Validation Data Presented for Upgraded Test at World Congress on Thyroid Cancer

Enhanced classifier identifies 30% more benign patients than original, flagship test Data from a clinical validation study presented at the 3rd World Congress on Thyroid Cancer (WCTC), held July 27-30 in Boston, Mass., demonstrate a next-generation version of a test widely used in thyroid cancer diagnoses can identify 30% more benign thyroid nodules among those...
Share

Childhood Exposure to Chernobyl Radiation Linked to Increased Risk of Thyroid Nodules

Children who were exposed to radiation following the Chernobyl nuclear accident in April 1986 may have an increased risk of developing thyroid nodules, according to a study recently published in The Journal of Clinical Endocrinology & Metabolism. Researchers led by Elizabeth K. Cahoon, SM, MHS, PhD, of the Radiation Epidemiology Branch, DCEG, at the National...
Share

ENDO 2017 Breaking News: Exposure to Common Flame Retardants May Raise the Risk of Papillary Thyroid Cancer

Some flame retardants used in many home products appear to be associated with the most common type of thyroid cancer, papillary thyroid cancer (PTC), according to a new study being presented Saturday at the Endocrine Society’s 99th annual meeting, ENDO 2017, in Orlando, Fla. “Thyroid cancer is the fastest increasing cancer in the U.S., with...
Share

Unique Biomarkers Identified for Use in Thyroid Cancer Follow-Up

Researchers have identified two unique biomarkers that show promise for monitoring patients who have received treatment for papillary thyroid cancer (PTC), according to a study recently published in the new open access Journal of the Endocrine Society. The team, led by Sebastiano Filetti, MD, of the Dipartimento di Medicina Interna e Specialitá Mediche, “Sapienza” Universitá...

Endocrine News provides the latest news and research articles on thyroid conditions and treatment. For more info read this month’s issue of Endocrine News.